SCHEDULE: Vanguard Reports 13.66% Stake in ResMed Inc.

The Vanguard Group has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 13.66% in ResMed Inc. as of September 30, 2025.

Summary

• The Vanguard Group, an investment adviser, reported beneficial ownership of 20,007,417.40 shares of ResMed Inc. common stock.
• This ownership represents 13.66% of ResMed Inc.'s class of securities.
• Vanguard holds sole voting power over 0.00 shares and shared voting power over 1,834,309.40 shares.
• Vanguard holds sole dispositive power over 17,643,708.00 shares and shared dispositive power over 2,363,709.40 shares.
• The holdings are in the form of depository receipts, with the CUSIP 761152107 assigned to the Ordinary Shares of the Issuer.
• Vanguard certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of ResMed Inc.

Sentiment

Score: 6

Explanation: The filing indicates a significant and stable institutional ownership by a major fund, which is generally viewed as a positive signal of confidence in the company, without any negative disclosures.

Positives

• A major institutional investor, The Vanguard Group, maintains a significant beneficial ownership stake of 13.66% in ResMed Inc., which can be interpreted as a vote of confidence in the company's long-term prospects.

Future Outlook

This filing does not contain any forward-looking statements or guidance from ResMed Inc. or The Vanguard Group regarding ResMed's future performance.

Management Comments

• The Vanguard Group certifies that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of ResMed Inc.

Industry Context

This filing primarily reflects an institutional investor's significant ownership stake in ResMed Inc., rather than providing insights into broader industry trends or competitive positioning. It indicates continued institutional interest in the medical device sector, particularly in companies like ResMed that specialize in respiratory care.

Stakeholder Impact

• Shareholders: The continued significant ownership by a major institutional investor like Vanguard may provide a level of stability and confidence for other shareholders.

Key Dates

Keywords

ResMed Inc., Vanguard Group, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Schedule 13G, RMD